Judy

China’s NMPA released over 80 new industry standards in February 2026 and revised GMP effective November 2026, enhancing quality management across device lifecycles. Class 1 devices face lighter immediate impacts via filings, while higher-risk classes require stricter registrant oversight and audits. International manufacturers must align QMS with these updates for continued market access. Check: Bio […]

The 2026 EU MDR marketing checklist requires all claims in medical device promotions to match the device’s intended purpose, backed by clinical evidence, while following Article 7 and national laws. Marketing materials like websites and brochures must avoid misleading info and undergo regulatory review. HHG GROUP supports MedTech firms through compliant trading platforms. Check: How

Navigating Japan’s PMDA and Korea’s MFDS requires understanding distinct regulatory pathways: Japan uses PMD Act classifications (Class I-IV) with MAH/DMAH requirements and PMDA review, targeting 12-month approvals; Korea’s MFDS employs four risk-based classes needing notification, certification, or approval. A modern procurement strategy aligns submissions early, leverages local representatives, and monitors harmonization to cut import delays

Medical devices sales in 2026 are shifting from relationship-driven approaches to data-centric strategies powered by analytics, digital platforms, and procurement alignment. Sales teams now focus on measurable outcomes, faster deal cycles, and seamless integration with hospital systems. Success depends on optimizing workflows, improving transparency, and leveraging platforms like HHG GROUP to connect with buyers efficiently

Healthcare procurement can significantly improve patient outcomes in postural orthostatic tachycardia syndrome (POTS) and broader dysautonomia care when it moves beyond cost reduction and instead focuses on sourcing specialized devices that enhance symptom control, functional capacity, and long‑term stability. By aligning purchasing decisions with clinical goals, quality‑of‑life measures, and readmission risk, organizations can deliver better

Automation in medical device assembly is transforming how MedTech manufacturers achieve near‑zero defect rates. By integrating AI, robotics, and sensor‑driven “smart factories,” companies can standardize assembly, detect anomalies in real time, and maintain continuous process improvement. For procurement teams, this means auditing a manufacturer’s assembly automation is now a prerequisite for long‑term, zero‑defect sourcing strategies.

Medical device shortages in 2026—especially in products like stereotactic breast biopsy needles and dialysis bloodlines—are expected to persist into Q4, disrupting surgical schedules and dialysis care. By diversifying vendors, monitoring the FDA medical device shortage list, and leveraging digital‑first procurement platforms such as HHG GROUP, health systems can build supply‑chain resilience and reduce OR‑level disruptions.

Medical device development progresses through defined stages including concept validation, structured design under ISO 13485, preclinical testing, regulatory approval, clinical trials, and commercialization. Each phase ensures safety, performance, and compliance. By integrating engineering, clinical evidence, and regulatory strategy, innovators successfully transform prototypes into market-ready solutions that improve patient outcomes and meet global healthcare standards. What

The top 10 medical device companies in 2026 by revenue and innovation include Medtronic ($33.5B), Johnson & Johnson MedTech ($31.9B), Medline Industries ($25.5B), Siemens Healthineers ($24.2B), Stryker ($22.6B), GE HealthCare ($19.7B), Royal Philips ($19.5B), Abbott ($19.0B), Boston Scientific ($16.7B), and BD ($15.1B), focusing on robotics, AI, and remote monitoring. What Are the Top Medical Device

Shockwave therapy and TenJet both effectively treat chronic tendon pain like tennis elbow and Achilles tendinitis. Shockwave uses acoustic waves to stimulate healing non-invasively, ideal for broad tissue regeneration. TenJet employs a precise saline jet to remove diseased tissue, suiting targeted cases. Choice depends on severity, with TenJet offering faster recovery but higher initial costs.